Lantern Pharma (LTRN) SEC Filings & 10K Form $3.34 -0.14 (-4.02%) Closing price 04:00 PM EasternExtended Trading$3.32 -0.02 (-0.75%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Lantern Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/15/20257:30 AMLantern Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/15/20257:35 AMLantern Pharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/29/20257:56 PMLantern Pharma (Filer)Form 10-K/A11/07/20248:09 PMLantern Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/26/20243:15 PMKEYSER D JEFFREY (Reporting)Lantern Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/17/20243:30 PMLantern Pharma (Issuer)Silberstein David S. (Reporting)Form 4Statement of changes in beneficial ownership of securities 07/17/20243:30 PMBhatia Kishor G. (Reporting)Lantern Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/17/20243:30 PMChandru Vijay (Reporting)Lantern Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/17/20243:30 PMLantern Pharma (Issuer)Margrave David R. (Reporting)Form 4Statement of changes in beneficial ownership of securities 07/17/20243:30 PMKEYSER D JEFFREY (Reporting)Lantern Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/17/20243:30 PMLantern Pharma (Issuer)Maccecchini Maria-Luisa (Reporting)Form 4Statement of changes in beneficial ownership of securities 07/17/20243:30 PMLantern Pharma (Issuer)SHARMA PANNA (Reporting)Form 4Statement of changes in beneficial ownership of securities 06/10/202411:16 PMLantern Pharma (Filer)Form EFFECT05/24/20243:06 PMLantern Pharma (Filer)Form S-3Registration statement under Securities Act of 1933 05/24/20243:08 PMLantern Pharma (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies PRME SEC Filings INMB SEC Filings TLSA SEC Filings MOLN SEC Filings ELDN SEC Filings OGI SEC Filings INBX SEC Filings PRQR SEC Filings HURA SEC Filings DMAC SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:LTRN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantern Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LTRN Stock Free LTRN Stock Alerts